Pharma intermediates are chemical building blocks used to make active pharmaceutical ingredients. Dye intermediates are building blocks used to make dyes and pigments. The chemistry can be similar, and some molecules are used in both, but the quality expectations are very different.
The main difference is the quality system. Pharma intermediates close to the final drug are made under good manufacturing practice, while dye intermediates are made under ordinary industrial quality control.
Where GMP applies
The international guideline for active pharmaceutical ingredients is ICH Q7. It applies good manufacturing practice from the point where the defined API starting material enters the process. Intermediates made after that point are expected to be made under GMP.
Intermediates made before that point are not formally covered by ICH Q7, but drug makers still usually expect documented quality control from their suppliers. Exactly which steps are covered for a given drug is set in its regulatory filing, so it varies.
How the expectations differ
These are the main practical differences a buyer sees:
- Documentation, since GMP needs batch records, validated methods and full traceability of every raw material.
- Change control, since a pharma supplier cannot change route, site or key raw material without notice and often regulatory review.
- Impurity control, since pharma buyers look for low limits on named impurities, residual solvents and potentially harmful impurities.
- Equipment and cleaning, since pharma lines need validated cleaning to prevent cross-contamination between products.
- Audits, since pharma customers and regulators audit suppliers regularly against written standards.
What this means for a dye buyer
Dye intermediates, by contrast, are usually judged on assay, shade performance and a few named impurities. Dye intermediate plants do not need GMP, and most do not have it. That is normal. You still need a clear specification, a consistent route and reliable testing. Our article on what purity dye intermediates should have explains how to set them.
Some plants make both kinds of product. That can be a good sign of discipline, but check that the dye products run on separate equipment where needed, and that the plant's best quality controls also apply to your product.
Ask the plant which of its lines and products run under GMP. Do not assume a pharma certificate covers the dye side. Check this during an audit of the intermediates plant.
Next step
We audit intermediates plants against the controls your product needs and check samples and documents before you order. To discuss your intermediates, book a free sourcing review.